A pharmaceutical company approached us for support with eight safety-related queries from the European Medicines Agency (EMA). The timescale to address the queries was three weeks.
Below, we explore how we worked with the client to deliver high-quality responses to the EMA’s safety queries within this tight deadline.

Explore insights on harmonizing pharmacovigilance documents, such as DSURs, RMPs, and PSURs, in our detailed whitepaper.
お問合せはこちら